Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly those targeting central nervous system disorders. Its structure supports the development of ligands for neurotransmitter receptors, making it valuable in creating potential antidepressants, antipsychotics, and anxiolytic agents. Also explored in the design of novel kinase inhibitors for cancer therapy due to its ability to enhance binding affinity and selectivity. Additionally, serves as a building block in the preparation of functionalized piperazine derivatives for use in medicinal chemistry and drug discovery programs.